TABLE 2.
Differences between females and males in frequency of vaccine-related side effectsa
| Dose and symptom | Sex | Symptom frequency (no.)b |
ORc | P value | |
|---|---|---|---|---|---|
| + | − | ||||
| 1st vaccine dose | |||||
| General fatigue | Female | 75 | 133 | 2.2 | 0.03 |
| Male | 11 | 43 | |||
| Headache | Female | 55 | 153 | 6.1 | <0.001 |
| Male | 3 | 51 | |||
| 2nd vaccine dose | |||||
| General fatigue | Female | 150 | 53 | 3.5 | <0.001 |
| Male | 24 | 30 | |||
| Headache | Female | 131 | 72 | 5.7 | <0.001 |
| Male | 13 | 41 | |||
| Chills | Female | 81 | 122 | 2.3 | 0.02 |
| Male | 12 | 42 | |||
| Fever (≥37.5°C) | Female | 69 | 134 | 4.1 | <0.001 |
| Male | 6 | 48 | |||
Significant differences (P < 0.05 by Fisher’s exact test) in frequency of vaccine-related side effects are shown. Results for all side effects are shown in Table S1 in the supplemental material.
+, Presence of a symptom; −, absence of a symptom.
OR, odds ratio.